201 related articles for article (PubMed ID: 21919621)
1. Molecular studies of the Oka varicella vaccine.
Quinlivan M; Breuer J; Schmid DS
Expert Rev Vaccines; 2011 Sep; 10(9):1321-36. PubMed ID: 21919621
[TBL] [Abstract][Full Text] [Related]
2. Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model.
Arvin AM
Herpes; 2006 Nov; 13(3):75-80. PubMed ID: 17147912
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse.
Moffat JF; Zerboni L; Kinchington PR; Grose C; Kaneshima H; Arvin AM
J Virol; 1998 Feb; 72(2):965-74. PubMed ID: 9444989
[TBL] [Abstract][Full Text] [Related]
4. Clinical and molecular aspects of the live attenuated Oka varicella vaccine.
Quinlivan M; Breuer J
Rev Med Virol; 2014 Jul; 24(4):254-73. PubMed ID: 24687808
[TBL] [Abstract][Full Text] [Related]
5. Varicella Virus Vaccination in the United States.
Shaw J; Gershon AA
Viral Immunol; 2018 Mar; 31(2):96-103. PubMed ID: 29173081
[TBL] [Abstract][Full Text] [Related]
6. Molecular studies of Varicella zoster virus.
Quinlivan M; Breuer J
Rev Med Virol; 2006; 16(4):225-50. PubMed ID: 16791838
[TBL] [Abstract][Full Text] [Related]
7. Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model.
Zerboni L; Hinchliffe S; Sommer MH; Ito H; Besser J; Stamatis S; Cheng J; Distefano D; Kraiouchkine N; Shaw A; Arvin AM
Virology; 2005 Feb; 332(1):337-46. PubMed ID: 15661165
[TBL] [Abstract][Full Text] [Related]
8. Analysis of United Kingdom wild-type strains of varicella-zoster virus: differentiation from the Oka vaccine strain.
Hawrami K; Breuer J
J Med Virol; 1997 Sep; 53(1):60-2. PubMed ID: 9298733
[TBL] [Abstract][Full Text] [Related]
9. Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies.
Freer G; Pistello M
New Microbiol; 2018 Apr; 41(2):95-105. PubMed ID: 29498740
[TBL] [Abstract][Full Text] [Related]
10. Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster.
Gershon AA; Gershon MD; Shapiro ED
J Infect Dis; 2021 Sep; 224(12 Suppl 2):S387-S397. PubMed ID: 34590140
[TBL] [Abstract][Full Text] [Related]
11. Investigation of varicella-zoster virus neurotropism and neurovirulence using SCID mouse-human DRG xenografts.
Zerboni L; Arvin A
J Neurovirol; 2011 Dec; 17(6):570-7. PubMed ID: 22161683
[TBL] [Abstract][Full Text] [Related]
12. Molecular and therapeutic aspects of varicella-zoster virus infection.
Quinlivan M; Breuer J
Expert Rev Mol Med; 2005 Aug; 7(15):1-24. PubMed ID: 16098235
[TBL] [Abstract][Full Text] [Related]
13. Varicella-zoster virus.
Arvin AM
Clin Microbiol Rev; 1996 Jul; 9(3):361-81. PubMed ID: 8809466
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of wild-type varicella-zoster strains from India and the Oka vaccine strain using a VZV open reading frame - 62 based PCR-RFLP technique.
Kaushik KS; Lahiri KK; Kapila K; Kumar S; Gupta RM; Karade S
Braz J Infect Dis; 2008 Aug; 12(4):313-5. PubMed ID: 19030732
[TBL] [Abstract][Full Text] [Related]
15. Varicella-zoster virus neurotropism in SCID mouse-human dorsal root ganglia xenografts.
Zerboni L; Reichelt M; Arvin A
Curr Top Microbiol Immunol; 2010; 342():255-76. PubMed ID: 20225014
[TBL] [Abstract][Full Text] [Related]
16. Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future?
Gershon AA
J Infect; 2017 Jun; 74 Suppl 1(Suppl 1):S27-S33. PubMed ID: 28646959
[TBL] [Abstract][Full Text] [Related]
17. Varicella zoster virus vaccines: potential complications and possible improvements.
Silver B; Zhu H
Virol Sin; 2014 Oct; 29(5):265-73. PubMed ID: 25358998
[TBL] [Abstract][Full Text] [Related]
18. The round trip model for severe herpes zoster caused by live attenuated varicella vaccine virus.
Grose C; Enquist LW
J Med Virol; 2020 Aug; 92(8):938-940. PubMed ID: 31943220
[TBL] [Abstract][Full Text] [Related]
19. [Varicella-zoster virus (VZV)].
Kanai K; Yamada S; Inoue N
Uirusu; 2010 Dec; 60(2):197-207. PubMed ID: 21488333
[TBL] [Abstract][Full Text] [Related]
20. Emerging drugs for varicella-zoster virus infections.
Andrei G; Snoeck R
Expert Opin Emerg Drugs; 2011 Sep; 16(3):507-35. PubMed ID: 21699441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
